生命科学资讯

China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says

Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time

Biotech investor Cormorant secures $150M for another SPAC deal

Express Scripts considering settlement in FTC insulin price lawsuit

The formula for biotech success in 2026: Confidence, resilience and funding

From detection to prevention: How sponsored testing can transform patient outcomes

The crucial role of raw material selection for success in cell therapy manufacturing

Sanofi to seek approval of touted eczema drug despite mixed results

Novo climbs higher on ‘strong’ Wegovy pill launch; Terns tweaks leukemia drug deal

Congress eyes tackling healthcare consolidation

Investors load Corxel with $287M for a ‘differentiated’ obesity pill

Bristol Myers buys into Janux’s ‘masked’ T cell engagers

FDA lays out new path to speed development of multiple myeloma drugs

BioMarin vets form Mendra to ‘modernize’ rare disease drug development

Corvus shares nearly triple on positive data for eczema pill

J&J eyes $100B in sales amid gains for cancer, immune drugs

Valneva to withdraw Chikungunya vaccine from US amid safety woes

GSK to buy Rapt in $2.2B deal for food allergy drug

Moderna cancer vaccine holds up; IO Biotech considers a sale

Kailera’s Ron Renaud on how a China-linked startup can compete in obesity